Breaking Medical News and In Depth Medical Stories

 
Search News:
     
PROGRAMS
 
 
Report examines bevacizumab for children with retinopathy of prematurity
Report examines bevacizumab for children with retinopathy of prematurity (August 19, 2014 - Insidermedicine) From Texas - A new report published in Ophthalmology examines outcomes among children treated with bevacizumab for retinopathy of prematurity. Researchers studied over 130 infants with retinopathy of prematurity with a mean age of 2.5 years. Participants were randomized to either intravitreal bevacizumab injections or laser therapy. Results showed that very high myopia occurred more among eyes that received laser therapy than those that received bevacizumab.
 
OUR TEAM
More...  
EDITORIAL BOARD
More...